TACE: a new target in epidermal growth factor receptor dependent tumors
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Cell Biology,Developmental Biology,Molecular Biology
Reference71 articles.
1. Phase II and tumor pharmacodynamic study of gefitinib in patients with advanced breast cancer;Baselga;J Clin Oncol,2005
2. (E)-2(R)-[1(S)-(hydroxycarbamoyl)-4-phenyl-3-butenyl]-2′-isobutyl-2′-(meth anesulfonyl)-4-methylvalerohydrazide (Ro 32-7315), a selective and orally active inhibitor of tumor necrosis factor-alpha convertase;Beck;J Pharmacol Exp Ther,2002
3. Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates GPIbalpha shedding from platelets in vitro and in vivo;Bergmeier;Circ Res,2004
4. EGFR gene amplification in breast cancer: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations;Bhargava;Mod Pathol,2005
5. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells;Black;Nature,1997
Cited by 56 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Phylogeny and expression of ADAM10 and ADAM17 homologs in lamprey;Fish Physiology and Biochemistry;2023-03-25
2. Analysis of A Disintegrin and Metalloprotease 17 (ADAM17) Expression as a Prognostic Marker in Ovarian Cancer Patients Undergoing First-Line Treatment Plus Bevacizumab;Diagnostics;2022-08-31
3. ADAM17—A Potential Blood-Based Biomarker for Detection of Early-Stage Ovarian Cancer;Cancers;2021-11-06
4. ADAM Metalloproteinases as Potential Drug Targets;Current Medicinal Chemistry;2019-07-25
5. Short hairpin RNA-mediated gene silencing of ADAM17 inhibits the growth of breast cancer MCF‑7 cells in�vitro and in�vivo and its mechanism of action;Oncology Reports;2018-01-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3